Provided by Tiger Fintech (Singapore) Pte. Ltd.

VIVA BIOTECH

1.510
+0.0100.67%
Volume:2.54M
Turnover:3.83M
Market Cap:3.21B
PE:17.62
High:1.530
Open:1.500
Low:1.480
Close:1.500
Loading ...

VIVA Biotech Holdings Conducted Annual General Meeting

Reuters
·
12 Jun

VIVA Biotech Holdings Issues Clarification on Connected Transaction with Nanjing Entities

Reuters
·
04 Jun

BRIEF-Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund

Reuters
·
28 May

VIVA Biotech - Fund Refers to Limited Partnership Fund to Be Named Nanjing Honghui Weitai Venture Capital Fund Partnership

THOMSON REUTERS
·
28 May

VIVA Biotech - Hangzhou Viva Zongchen Agreed to Invest RMB25.0 Mln to Fund

THOMSON REUTERS
·
28 May

Viva Biotech Holdings' (HKG:1873) Shares Bounce 29% But Its Business Still Trails The Industry

Simply Wall St.
·
30 Mar

Viva Biotech's Pharma Unit Passes US FDA Onsite Inspection

MT Newswires Live
·
28 Mar

Press Release: Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D

Dow Jones
·
27 Mar

BRIEF-Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical

Reuters
·
27 Mar

VIVA Biotech - Passing of U.S. FDA on-Site Inspection by Langhua Pharmaceutical

THOMSON REUTERS
·
27 Mar

VIVA Biotech Holdings FY Revenue RMB 1,986.7 Million

THOMSON REUTERS
·
27 Mar

VIVA Biotech Holdings FY Gross Profit RMB 687.4 Million

THOMSON REUTERS
·
27 Mar

Viva Biotech to Turn to 2024 Profit

MT Newswires Live
·
14 Mar

BRIEF-Viva Biotech Holdings Expects Net Profit Of RMB210 Million To RMB240 Million For 2024

Reuters
·
13 Mar

VIVA Biotech - Net Profit Attributable Expected to Be RMB150 Mln to RMB180 Mln for Year

THOMSON REUTERS
·
13 Mar

GF Securities Starts Viva Biotech at Buy with HK$2.41 Price Target

MT Newswires Live
·
13 Mar